MBRX - Moleculin Biotech, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
0
0
Cost of Revenue
-
-
-
-
Gross Profit
-
-
-
-
Operating Expenses
Research Development
10,743
9,728
4,545
1,496
Selling General and Administrative
6,118
5,229
4,090
2,381
Total Operating Expenses
17,049
15,025
8,653
3,883
Operating Income or Loss
-17,049
-15,025
-8,653
-3,883
Interest Expense
-
-
-
43
Total Other Income/Expenses Net
4,618
3,145
-1,152
0
Income Before Tax
-12,422
-11,876
-9,805
-3,926
Income Tax Expense
-
-
-
-
Income from Continuing Operations
-12,193
-11,876
-9,805
-3,926
Net Income
-12,193
-11,876
-9,805
-3,926
Net Income available to common shareholders
-12,193
-11,876
-9,805
-3,926
Reported EPS
Basic
-
-0.46
-0.53
-0.40
Diluted
-
-0.46
-0.53
-0.40
Weighted average shares outstanding
Basic
-
25,904
18,569
9,828
Diluted
-
25,904
18,569
9,828
EBITDA
-
-14,957
-8,635
-3,877